Is PolyPid Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, PolyPid Ltd (PYPD) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is PolyPid Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes PolyPid Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of PolyPid Ltd?

Muslim investors may consider investing in PolyPid Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is PolyPid Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of PolyPid Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for PolyPid Ltd updated?

The Shariah compliance status of PolyPid Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like PolyPid Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of PolyPid Ltd?

You can check the latest Shariah compliance status of PolyPid Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

PYPD Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 07, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for PolyPid Ltd (PYPD)

Based on 10 analysts giving stock ratings to PolyPid Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

PolyPid Ltd. Stock Analysis PYPD

United States Health Care Micro Cap Report: 2025 Annual

PolyPid Ltd. operates as a phase 3 biopharma company. The company is headquartered in Petah Tikva, Central(Hamerkaz) and currently employs 69 full-time employees. The company went IPO on 2020-06-26. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Key Statistics of PolyPid Ltd (PYPD)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$4.25$4.65

Today's Open

$4.30

Volume

110.03K

P/E Ratio (TTM)

52 Week Range

$2.44$5.12

Market Cap

85.87M

Avg. Volume

53.85K

Dividend Yield

Financial Metrics & Statements of PolyPid Ltd (PYPD)

FAQ's for PolyPid Ltd (PYPD)

According to Musaffa’s Shariah screening methodology, PolyPid Ltd (PYPD) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.